Pacific Horizon Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Professionals
  • 2

Professionals

  • Investments
  • 44

  • Exits
  • 31

Exits

Pacific Horizon Ventures General Information

Company Description

Founded in 1993, Pacific Horizon Ventures was a venture capital firm based in Seattle, Washington. The firm used to invest in early-stage companies in life science and healthcare companies operating in the biotechnology, pharmaceutical chemistry, medical devices, computational biology, and genomics sectors.

Business Details

Year Founded
1993
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • 500 Union Street
  • Suite 835
  • Seattle, WA 98101
  • United States

Pacific Horizon Ventures Investments & Acquisitions (44)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Koronis Pharmaceuticals 01-Sep-2016 Merger/Acquisition Drug Discovery Profitable
SleepMed 09-Apr-2015 Laboratory Services (Healthcare) Generating Revenue
Illumigen Biosciences 11-Oct-2007 Drug Discovery Pre-Clinical Trials
ViaCyte 16-Jul-2007 Drug Discovery Clinical Trials - Phase 2
Koronis Pharmaceuticals 28-Jun-2007 Drug Discovery Profitable
iScience Interventional 29-Mar-2007 Other Pharmaceuticals and Biotechnology Generating Revenue
Allegro Biodiesel 04-Oct-2006 Energy Production Out of Business
ViaCyte 30-Jun-2006 Drug Discovery Clinical Trials - Phase 2
iScience Interventional 31-May-2005 Later Stage VC Other Pharmaceuticals and Biotechnology Generating Revenue
Transmolecular 01-Mar-2004 Later Stage VC Biotechnology Generating Revenue
You’re viewing 10 of 44 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pacific Horizon Ventures Exits (31)

Company Name Exit Date Exit Type Exit Size
ViaCyte 27-Sep-2022 Merger/Acquisition
SleepMed 08-Jun-2019
Tandem Medical 01-Jan-2018
Argos Therapeutics 07-Feb-2014
iScience Interventional 31-Dec-2013
Selective Genetics 01-Jan-2013
Inhibitex 13-Feb-2012
Trimeris 03-Nov-2011
Norian 24-May-2011 Merger/Acquisition
Transmolecular 01-Mar-2011 Merger/Acquisition
You’re viewing 10 of 31 exits. Get the full list »

Pacific Horizon Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Pacific Horizon Ventures FAQs

  • What is Pacific Horizon Ventures?

    Founded in 1993, Pacific Horizon Ventures was a venture capital firm based in Seattle, Washington.

  • When was Pacific Horizon Ventures founded?

    Pacific Horizon Ventures was founded in 1993.

  • Where is Pacific Horizon Ventures headquartered?

    Pacific Horizon Ventures is headquartered in Seattle, WA.

  • What is Pacific Horizon Ventures's total asset value?

    Pacific Horizon Ventures has around in total assets under management.

  • How many investments has Pacific Horizon Ventures made?

    Pacific Horizon Ventures has made 44 investments.

  • What has Pacific Horizon Ventures invested in?

    Pacific Horizon Ventures has made numerous investments in companies like Koronis Pharmaceuticals, SleepMed, and Illumigen Biosciences within the Drug Discovery and Laboratory Services (Healthcare) industries.

  • What has Pacific Horizon Ventures invested in recently?

    Pacific Horizon Ventures's latest investment was on 01-Sep-2016 in Koronis Pharmaceuticals, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »